Metagenomi, Inc. Common Stock (MGX)
Automate Your Wheel Strategy on MGX
With Tiblio's Option Bot, you can configure your own wheel strategy including MGX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol MGX
- Rev/Share 0.9088
- Book/Share 5.2704
- PB 0.4174
- Debt/Equity 0.2195
- CurrentRatio 6.3635
- ROIC -0.3623
- MktCap 82572899.0
- FreeCF/Share -2.6632
- PFCF -0.8344
- PE -0.9383
- Debt/Assets 0.1579
- DivYield 0
- ROE -0.3876
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 5
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Here's Why Metagenomi (MGX) is a Great Momentum Stock to Buy
Published: October 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Does Metagenomi (MGX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Read More
Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference
Published: February 11, 2025 by: GlobeNewsWire
Sentiment: Neutral
EMERYVILLE, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing toolbox, today announced that Brian C. Thomas, PhD, CEO and founder of Metagenomi, will participate in a fireside chat at TD Cowen's 45th Annual Health Care Conference on Wednesday, March 5, 2025, from 1:10-1:40 p.m. ET in Boston. The company will host one-on-one investor meetings at the conference.
Read More
About Metagenomi, Inc. Common Stock (MGX)
- IPO Date 2006-04-06
- Website https://www.metagenomi.co
- Industry Biotechnology
- CEO Brian Charles Thomas
- Employees 202